menu search

ACXP / Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023
Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive question and answer session at the Emerging Growth Conference STATEN ISLAND, N.Y. , Jan. 16, 2023  /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, is pleased to announce that it has been invited to present at the Emerging Growth Conference on January 25, 2023. Read More
Posted: Jan 16 2023, 08:01
Author Name: PRNewsWire
Views: 110820

ACXP News  

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 16, 2023

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2022 Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP ) Q4 2022 Earnings Conference Call March 16, 2023 8:00 AM ET Company Participants Robert Shawah - Co-Founder more_horizontal

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023

By PRNewsWire
January 16, 2023

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on January 25, 2023

Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive question and answer session more_horizontal

Acurx Pharmaceuticals, Inc.'s (ACXP) CEO David Luci on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 11, 2022

Acurx Pharmaceuticals, Inc.'s (ACXP) CEO David Luci on Q1 2022 Results - Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Rob Shawah - Chief Financial more_horizontal


Search within

Pages Search Results: